The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review
Open accessAbstract
BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) has been implicated as a cause of hepatocellular carcinoma (HCC). We performed a systematic review of epidemiology studies to confirm the association between these disorders. METHODS: We searched PubMed for original reports published from January 1992 to December 2011 that evaluated the association between NAFLD, nonalcoholic steatohepatitis (NASH), cryptogenic cirrhosis presumed to be NASH-related, and the risk of HCC. Studies were categorized as offering potential direct evidence (eg, cohort studies) or indirect evidence (eg, case-control, cross-sectional, or case-series studies) for an association. We analyzed data from a total of 17 cohort studies (3 population based, 9 clinic based [6 limited to patients with cirrhosis], and 5 natural history), 18 case-control and cross-sectional studies, and 26 case series. RESULTS: NAFLD or NASH cohorts with few or no cases of cirrhosis cases had a minimal risk for HCC (cumulative HCC mortality of 0%-3% for study periods up to 20 y). Cohorts with NASH and cirrhosis had a consistently higher risk (cumulative incidence ranging from 2.4% over 7 y to 12.8% over 3 y). However, the risk for HCC was substantially lower in these cohorts than for cohorts with hepatitis C-related cirrhosis. Factors that increased risk among cohorts with NASH and cirrhosis could not be determined, because most studies were not sufficiently powered for multivariate analysis. CONCLUSIONS: This systematic review shows that despite several limitations, there is epidemiologic evidence to support an association between NAFLD or NASH and an increased risk of HCC; risk seems to be limited to individuals with cirrhosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A systematic review and a metaanalysis concluded that the risk estimate is likely too low to justify routine screening in MASLD without evidence of advanced fi brosis. 241”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [241]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the HCC incidence in individuals without cirrhosis is very low, ranging from 0.08 to 0.63 per 1,000 PY. 240 -244”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [241]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Thomas, A. C., & Campbell, J. H. (2000) · Cited by 2,800
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302
Williams, C. D., Stengel, J. Z., Asike, M., Torres, D. M., Shaw, J. C., Contreras, M., Landt, C. L., & Harrison, S. A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.09.038 · Cited by 2,182
Bugianesi, E., Leone, N., Vanni, E., Marchesini, G., Brunello, F., CARUCCI, P., Musso, A., Paolis, P. D., Capussotti, L., Salizzoni, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.34168 · Cited by 1,436
Musso, G., Gambino, R., Cassader, M., & Pagano, G. (2010) · Annals of Medicine · doi:10.3109/07853890.2010.518623 · Cited by 1,304
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 773
Evaluation of safety for hepatectomy in a novel mouse model with nonalcoholic-steatohepatitis
Ozawa, Y., Tamura, T., Owada, Y., Shimizu, Y., Kemmochi, A., Hisakura, K., Matsuzaka, T., Shimano, H., Isoda, H., & Ohkohchi, N. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i15.1622 · Cited by 10
Farrell, A., Ryan, M. C., & Howell, J. A. (2020) · Hepatoma Research · doi:10.20517/2394-5079.2019.019 · Cited by 9
Evaluation of liver transplant candidates with non-alcoholic steatohepatitis
Esteban, J. P., & Asgharpour, A. (2021) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2020.03.04 · Cited by 9
Chao, H., & Lin, H.-Y. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.724426 · Cited by 10
Epidemiology of Hepatocellular Carcinoma
White, D. L., Kanwal, F., Jiao, L., & El‐Serag, H. B. (2016) · Springer eBooks · doi:10.1007/978-3-319-34214-6_1 · Cited by 10
Mikuriya, Y., Tashiro, H., Kobayashi, T., Kuroda, S., Abe, T., Hashimoto, M., & Ohdan, H. (2015) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-015-1295-x · Cited by 10
Ali, M., Laçin, Ş., Abdel‐Wahab, R., Uemura, M. I., Hassan, M. M., Rashid, A., Duda, D. G., & Kaseb, A. O. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s111681 · Cited by 10
Peta, V., Zhu, J., Lubman, D. M., Huguet, S., Imbert‐Bismut, F., Bolbach, G., Clodic, G., Mathéron, L., Ngo, Y., Pais, R., et al. (2020) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2019.12.010 · Cited by 10
Barsamian, C., Carette, C., Sasso, M., Poghosyan, T., Bédossa, P., Emile, J., Parlier, D., Miette, V., Bouillot, J., Czernichow, S., et al. (2020) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.02.010 · Cited by 10
Oliveira, C., Stefano, J., & Carrilho, F. (2017) · Hepatobiliary surgery and nutrition · doi:10.21037/hbsn.2017.06.06 · Cited by 25
Liccioni, A., Reig, M., & Bruix, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-34062-5.00091-1 · Cited by 9
Ge, J.-Y., Bai, Y.-N., Tang, B., Wei, D., & Yan, M.-L. (2021) · Journal of Oncology · doi:10.1155/2021/6630535 · Cited by 9
Steatosis, Steatohepatitis and Cancer Immunotherapy: An Intricate Story
Cataldi, M., Manco, F., & Tarantino, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312947 · Cited by 9
Wei, M., Zhang, T., Ouyang, H., Huang, Z., Lü, B., Li, J., Xu, H., Wang, Z., & Ji, L. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175744 · Cited by 9
Chou, Y.-T., Li, C., Sun, Z., Shen, W.-C., Yang, Y., Lu, F., Chang, C., & Wu, J. (2021) · Nutrients · doi:10.3390/nu13030914 · Cited by 9
Clinical outcome of non-alcoholic fatty liver disease: an 11-year follow-up study
Tang, X., Shi, Y., Du, J., Hu, K., Zhou, T., Chen, L., Zhang, Y., Li, F., Zhang, H., Liebe, R., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-054891 · Cited by 10
Interdisciplinary advances reshape the delivery tools for effective NASH treatment
Chen, L., & Wang, Y. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101730 · Cited by 9
NAFLD and Cardiovascular Disease: Can the Real Association Be Determined?
Trivedi, I., & Rinella, M. E. (2014) · Current Hepatology Reports · doi:10.1007/s11901-014-0231-9 · Cited by 9
Montesi, L., Mazzotti, A., Moscatiello, S., Forlani, G., & Marchesini, G. (2013) · Hepatology International · doi:10.1007/s12072-013-9451-2 · Cited by 9
Shi, S.-F., KE, J.-J., Xu, Q., Wu, W. Q., & WAN, Y. Y. (2018) · Neoplasma · doi:10.4149/neo_2018_161215n642 · Cited by 9
Molecular and metabolic mechanisms underlying the obesity-cancer link
O’Flanagan, C. H., Bowers, L. W., Allott, E. H., & Hursting, S. D. (2018) · Research Portal (Queen's University Belfast) · Cited by 9
NAFLD Fibrosis Score: Is It Ready for Wider Use in Clinical Practice and for Clinical Trials?
Gawrieh, S., & Chalasani, N. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.025 · Cited by 9
Liver Transplantation for Nonalcoholic Steatohepatitis
Asrani, S. K. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.11.014 · Cited by 9
Akarca, U. S., Ünsal, B., Sezgın, O., Yalçın, K., Akdoğan, M., Gönen, C., Gündüz, F., Özeni̇rler, S., Sonsuz, A., Dinçer, D., et al. (2021) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2021.201171 · Cited by 8
Chen, S., Wu, K., Ke, Y., Chen, S., He, R., Zhang, Q., Shen, C., Li, Q., Ruan, Y., Zhu, Y., et al. (2024) · Medicine · doi:10.1097/md.0000000000039613 · Cited by 8
Sobrevida en pacientes con cirrosis de acuerdo con su etiología. Cohorte retrospectiva
Ortíz, J. E. P., Orjuela, N. G., Pardo, S. S., Ortíz, R. G. P., & Eslava-Schmalbach, J. H. (2022) · Revista Colombiana de Gastroenterología · doi:10.22516/25007440.703 · Cited by 8
Yendewa, G. A., Khazan, A., & Jacobson, J. M. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae014 · Cited by 8
A Simple Index for Nonalcoholic Steatohepatitis—HUFA—Based on Routinely Performed Blood Tests
Ćulafić, M., Kovačević, S. V., Dopsaj, V., Štulić, M., Vlaisavljević, Ž., Miljković, B., & Culafic, D. (2019) · Medicina · doi:10.3390/medicina55060243 · Cited by 8
[11C]acetate PET as a tool for diagnosis of liver steatosis
Nejabat, M., Leisser, A., Karanikas, G., Wadsak, W., Mitterhauser, M., Mayerhoefer, M. E., Kienbacher, C., Trauner, M. A., Hacker, M., & Haug, A. R. (2018) · Abdominal Radiology · doi:10.1007/s00261-018-1558-4 · Cited by 8
Weinstein, R. B., Parikh-Das, A. M., Salonga, R., Schuemie, M. J., Ryan, P. B., Atillasoy, E. O., Hermanowski‐Vosatka, A., Eichenbaum, G. M., & Berlin, J. A. (2021) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2021.105043 · Cited by 8
Toman, D., Şengül, İ., Pelikán, A., Şengül, D., Vavra, P., Ihnat, P. M., Roman, J., & Kayaalp, C. (2022) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20220268 · Cited by 9
Surveillance for Hepatocellular Carcinoma: Evidence Guidelines and Utilization
Shoreibah, M., Bloomer, J. R., McGuire, B. M., & Massoud, O. I. (2013) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000200 · Cited by 8
The Changing Liver Transplant Waitlist: An Emerging Liver Purgatory?
Asrani, S. K., & O’Leary, J. G. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.01.011 · Cited by 8
Noninvasive Methods of Assessing Nonalcoholic Fatty Liver Disease: What the Clinician Needs to Know
Torres, D. M., & Harrison, S. A. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.05.040 · Cited by 8
Role of Hepatocyte Nuclear Factor 4 Alpha in Liver Cancer
Kotulkar, M., Paine‐Cabrera, D., & Apte, U. M. (2024) · Seminars in Liver Disease · doi:10.1055/a-2349-7236 · Cited by 7
Cerrito, L., Mignini, I., Ainora, M. E., Mosoni, C., Gasbarrini, A., & Zocco, M. A. (2023) · Cancers · doi:10.3390/cancers15030637 · Cited by 7
Prevention Strategies for Hepatocellular Carcinoma
Erstad, D. J., Razavi, A. A., Shen, L., Tanabe, K. K., & Fuchs, B. C. (2019) · Molecular and translational medicine · doi:10.1007/978-3-030-21540-8_13 · Cited by 7
Leu, Y., Chen, Y.-J., Chen, C., & Huang, H.-L. (2019) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x19500708 · Cited by 7
Kawaguchi, S., Sakuraba, H., Horiuchi, M., Ding, J., Matsumiya, T., Seya, K., Iino, C., Endo, T., Kikuchi, H., Yoshida, S., et al. (2021) · Inflammation · doi:10.1007/s10753-021-01550-8 · Cited by 7
Haque, E., Śmiech, M., Łuczyńska, K., Bouchard, M. F., Viger, R. S., Kono, H., Pierzchała, M., & Taniguchi, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105296 · Cited by 7
Non-alcoholic fatty liver disease: time for changes
Yefimenko, T. I., & Mykytyuk, M. (2021) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.17.4.2021.237350 · Cited by 7
Clinical Phenotyping and the Application of Precision Medicine in MAFLD
Saffo, S., & Do, A. (2022) · Clinical Liver Disease · doi:10.1002/cld.1199 · Cited by 7
Familial clustering of hepatocellular carcinoma in HBsAg-positive patients in the United States
Tong, M. J., Huynh, T. T., & Siripongsakun, S. (2013) · Hepatology International · doi:10.1007/s12072-013-9447-y · Cited by 7
The changing characteristics of hepatocellular cancer in Hawaii over time
Wong, L. L., Ogihara, M., Ji, J., & Tsai, N. C. S. (2014) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2014.06.036 · Cited by 7
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
Chung, R., & Mittal, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-48662-8_6 · Cited by 7
Focus on gastrointestinal and liver cancers
Wu, W. K. K., & Sung, J. J. �. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.09.006 · Cited by 7
Singal, A. G., & Marrero, J. A. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch109 · Cited by 7
Kubiliun, M. J., & Marrero, J. A. (2017) · Wiley eBooks · doi:10.1002/9781119251316.ch36 · Cited by 7
Exercise, weight maintenance, and nonalcoholic fatty liver disease risk: a Chinese cohort study
Yang, C., Yan, P., Deng, J., Li, Y., Jiang, X., & Zhang, B. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1359476 · Cited by 6
Boonkaew, B., Charoenthanakitkul, D., Suntornnont, N., Ariyachet, C., & Tangkijvanich, P. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i9.108259 · Cited by 10
Stoopen-Rometti, M., Encinas-Escobar, E. R., Ramírez-Carmona, C. R., Wolpert-Barraza, E., Kimura‐Hayama, E., Sosa-Lozano, L. A., Favila, R., Kimura-Fujikami, Y., Saavedra-Abril, J. A., & Loaeza-del Castillo, A. (2017) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2017.01.003 · Cited by 6
Kumar, A., Narang, R. K., & Bhatia, R. (2023) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2023.136272 · Cited by 6
Do, A., Ilagan‐Ying, Y. C., Mehal, W. Z., & Lim, J. K. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1811674 · Cited by 7
Hepatocellular Carcinoma: the Impact of NAFLD
Allaire, M., Dupont, B., Nahon, P., Ganne-Carrié, N., & Nault, J. (2016) · Current Hepatology Reports · doi:10.1007/s11901-016-0303-0 · Cited by 3
Lee, H. A. (2024) · Ewha Medical Journal · doi:10.12771/emj.2024.e65 · Cited by 5
Cholankeril, G. T., & El‐Serag, H. B. (2022) · Seminars in Liver Disease · doi:10.1055/a-1957-8540 · Cited by 5
Gillessen, J., Reuken, P. A., Hunyady, P., Reichert, M., Lothschütz, L., Finkelmeier, F., Nowka, M., Allo, G., Kütting, F., Bürger, M., et al. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00201 · Cited by 6
NASH/NAFLD-Related Hepatocellular Carcinoma: An Added Burden
Georgescu, D., Lighezan, D., Rosca, C. I., Nistor, D., Ancusa, O., Suceava, I., Iancu, M. A., & Kundnani, N. R. (2023) · Life · doi:10.3390/life14010025 · Cited by 6
Fluorescence-guided Surgery for Hepatocellular Carcinoma: From Clinical Practice to Laboratories
Xiao, T., Chen, D., Li, P., Li, Z., Pan, W., Dong, Y., Zhang, J., & Li, M. (2025) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2024.00375 · Cited by 5
Labgaa, I., Torrecilla, S., Martinez-Quetglas, I., & Sia, D. (2017) · Digestive Disease Interventions · doi:10.1055/s-0037-1603577 · Cited by 5
Bevers, T. B., El‐Serag, H. B., Hanash, S., Thrift, A. P., Tsai, K. Y., Maresso, K. C., & Hawk, E. T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00023-2 · Cited by 9
Sharaf, A. L., Elbadrawy, E., Abdellatif, A., & Monem, N. A. A. (2021) · Afro-Egyptian Journal of Infectious and Endemic Diseases · doi:10.21608/aeji.2021.98381.1183 · Cited by 5
RISK FACTORS FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
Cavalcante, L. N., Dezan, M. G. F., Paz, C. L. D. S. L., & Lyra, A. D. (2022) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.202204000-93 · Cited by 5
Continuous Shear Wave Elastography for Liver Using Frame-to-Frame Equalization of Complex Amplitude
Tano, N., Koda, R., Tanigawa, S., Kamiyama, N., Yamakoshi, Y., & Tabaru, M. (2024) · Ultrasonic Imaging · doi:10.1177/01617346241247127 · Cited by 5
Clinical Epidemiology of Chronic Liver Disease: Hepatocellular Carcinoma
Suraweera, D., Konyn, P., Vu, T., & Saab, S. (2018) · Clinical Epidemiology of Chronic Liver Diseases · doi:10.1007/978-3-319-94355-8_15 · Cited by 6
Surveillance for hepatocellular carcinoma - current status and advances
Chen, K., Chang, J. P.-E., Goh, G. B., & Tan, C. (2018) · Hepatoma Research · doi:10.20517/2394-5079.2018.103 · Cited by 5
New Names, New Drugs, Better Outcomes in Steatotic Liver Disease
Peverelle, M., Mbelle, M., & Joshi, D. (2025) · British Journal of Hospital Medicine · doi:10.12968/hmed.2024.0655 · Cited by 4
Zeng, C., Liu, S., Li, H., & Han, X. W. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1644677 · Cited by 4
Sugawara, T., Hitaka, K., Matsumoto, M., Nakamura, S., Kobayashi, R., Kandori, H., & Nio, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-24927-3 · Cited by 5
Hepatocellular Carcinoma: A Pharmacological Aspect
Sharma, M., Chouhan, N. K., & Vaidya, S. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.92083 · Cited by 4
Nguyen, M., Amoon, A. T., Lee, L., Chiang, V., Nham, K., Sun, A., Ji, M., Sundin, P., Bastani, R., & Flóres, Y. N. (2021) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2021.22.6.1737 · Cited by 4
Schattenberg, J. M., Balp, M., Reinhart, B., Porwal, S., Tietz, A., Pedrosa, M. C., & Docherty, M. (2023) · Gastro Hep Advances · doi:10.1016/j.gastha.2023.09.004 · Cited by 5
Michalczuk, M. T., Longo, L., Keingeski, M. B., Basso, B. D. S., Guerreiro, G. T. S., Ferrari, J. T., Vargas, J. E., de Oliveira, C. P. M. S., Cruz, C. U., Cerski, C. T. S., et al. (2024) · World Journal of Hepatology · doi:10.4254/wjh.v16.i1.75 · Cited by 6
Llamoza-Torres, C. J., Fuentes-Pardo, M., & Ramos‐Molina, B. (2024) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2024.64 · Cited by 6
Nirei, K., Ogihara, N., Kawamura, W., Kang, W., & Moriyama, M. (2013) · Case Reports in Gastroenterology · doi:10.1159/000347154 · Cited by 4
Metabolic Syndrome–Related Hepatocellular Carcinoma Treated by Volumetric Modulated Arc Therapy
Klein, J., Dawson, L. A., Tran, T., Adeyi, O. A., Purdie, T. G., Sherman, M. D., & Brade, A. M. (2014) · Current Oncology · doi:10.3747/co.21.1756 · Cited by 4
Abdominelle Sonografie bei Patienten mit Diabetes mellitus. Teil 1: Leber
Jenssen, C., Pietsch, C., Gottschalk, U., Barreiros, A. M., Teufel, A., Cui, X., & Dietrich, C. F. (2015) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0034-1398949 · Cited by 5
Similarities and Differences Between Nonalcoholic Steatohepatitis and Other Causes of Cirrhosis
Samji, N. S., Heda, R. P., Kovalic, A. J., & Satapathy, S. K. (2019) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2019.09.004 · Cited by 4
Roesch-Dietlen, F., Pérez-Morales, A. G., Grube-Pagola, P., González-Santes, M., Díaz-Roesch, F., Triana‐Romero, A., Roesch-Ramos, L., Remes-Troche, J. M., & Cruz-Aguilar, M. (2023) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2021.09.006 · Cited by 4
Batt, N., Rodrigues, B. T., Bloom, S., Sawhney, R., George, E., Hodge, A. D., Vootukuru, N., McCrae, C. S., Sood, S., Roberts, S. K., et al. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16501 · Cited by 4
Zhu, J.-Q., Liu, J.-Z., Yang, S., Ren, Z., Ye, X.-Y., Liu, Z., Li, X., Han, D., & He, Q. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1306091 · Cited by 4
Başaranoğlu, M., Najjar, S. M., Demirbağ, A. E., & Şentürk, H. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i7.376 · Cited by 4
Non-alcoholic Fatty Liver Disease
Kim, S. F., & Choi, J. H. (2023) · Springer eBooks · doi:10.1007/978-3-031-40116-9_36 · Cited by 4
Diagnostic and Prognostic Performance of Liquid Biopsy in Hepatocellular Carcinoma
Labgaa, I., Craig, A. J., & Villanueva, A. (2017) · Current clinical pathology · doi:10.1007/978-3-319-55661-1_14 · Cited by 4
Prenner, S. B., & Kulik, L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00046-x · Cited by 5
Bariatric surgery, obesity and liver transplantation
Ahmed, Z., Khan, M. A., Vazquez‐Montesino, L. M., & Ahmed, A. (2021) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh-2019-ltna-15 · Cited by 4
Zhu, J.-Q., Ye, X.-Y., Yang, S.-W., Liu, J.-Z., Ren, Z., Jia, Y., Liu, Z., Ding, C., Kou, J.-T., Li, X.-L., et al. (2023) · European Journal of Clinical Nutrition · doi:10.1038/s41430-023-01363-y · Cited by 3
Cui, T., Guan, C., Song, K., & Yu, J. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2025.1623789 · Cited by 3
Chayama, K., Hiramatsu, A., Shima, T., Itoh, Y., Yamaguchi, K., Nakajima, T., Hoshikawa, K. T., Kawamura, Y., Akuta, N., Ito, K., et al. (2023) · Hepatology Research · doi:10.1111/hepr.13950 · Cited by 3
Samarasinghe, S. M., Hewage, A. S., Siriwardana, R. C., Tennekoon, K. H., Niriella, M. A., Silva, S. D., & Abeysuriya, V. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03738-w · Cited by 3
NAFLD-Associated Hepatocellular Carcinoma: a Threat to Patients with Metabolic Disorders
Sasdelli, A., Brodosi, L., & Marchesini, G. (2016) · Current Hepatology Reports · doi:10.1007/s11901-016-0297-7 · Cited by 3
Stoopen-Rometti, M., Encinas-Escobar, E. R., Ramírez-Carmona, C. R., Wolpert-Barraza, E., Kimura‐Hayama, E., Sosa-Lozano, L. A., Favila, R., Kimura-Fujikami, Y., Saavedra-Abril, J. A., & Loaeza-del Castillo, A. (2017) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2016.06.001 · Cited by 3
Foog, D. H.-S., Kwok, D., Yu, B., & Wong, V. (2017) · Current Hepatology Reports · doi:10.1007/s11901-017-0376-4 · Cited by 6
Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease
Jukić, L. V. (2021) · Acta Clinica Croatica · doi:10.20471/acc.2021.60.s1.03 · Cited by 3
Gado, T. H., Asal, S. A., Abdelraouf, F. H., & Samie, R. M. A. (2022) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2022.9354 · Cited by 3
Risk Stratification for Hepatocellular Carcinoma in Patients with Non-alcoholic Fatty Liver Disease
Truong, E., Han, C., Muthiah, M. D., & Noureddin, M. (2023) · Current Hepatology Reports · doi:10.1007/s11901-023-00595-7 · Cited by 3
Overall survival of patients with hepatocellular carcinoma of different etiologies
Petkau, V. V., Николаевна, Б. Е., Breder, V. V., Киселев, Е. А., & Kiseleva, K. E. (2023) · Practical oncology · doi:10.31917/2401071 · Cited by 3
Natural History of Nonalcoholic Fatty Liver Disease
Ismaiel, A., Portincasa, P., & Dumitrascu, D. L. (2023) · Springer eBooks · doi:10.1007/978-3-031-33548-8_3 · Cited by 3
Lominadze, Z., Shaik, M. R., Choi, D., Zaffar, D., Mishra, L., & Shetty, K. (2023) · Cancer Journal · doi:10.1097/ppo.0000000000000682 · Cited by 2
Roesch-Dietlen, F., Pérez-Morales, A. G., Grube-Pagola, P., González-Santes, M., Díaz-Roesch, F., Triana‐Romero, A., Roesch-Ramos, L., Remes-Troche, J. M., & Cruz-Aguilar, M. (2022) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2021.09.003 · Cited by 3
Metadata
- Authors
- White, D. L., Kanwal, F., & El–Serag, H. B.
- Affiliations
- Michael E. DeBakey VA Medical Center (US)
- Corresponding author
- White, Donna L.
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 10
- Issue
- 12
- Pages
- 1342-1359.e2
- ISSN
- 1542-3565 (ISSN-L)
- PMC
- PMC3501546
- OpenAlex
- W1975567145
- Cited by
- 766
- References
- 73
- Citations by year
- 2026: 16 · 2025: 26 · 2024: 39 · 2023: 49 · 2022: 61 · 2021: 71 · 2020: 68 · 2019: 64 · 2018: 76 · 2017: 73 · 2016: 54 · 2015: 58 · 2014: 54 · 2013: 56
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Clinical Gastroenterology and Hepatology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (HFP90-020, DK56338)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK56338, K24DK078154, K24 DK081736-01, K01 DK078154-03, K01DK081736, P30DK056338)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, hepatocellular carcinoma, liver cirrhosis, cryptogenic cirrhosis, cancer risk, HCC mortality
- MeSH terms
- Fatty Liver, Humans, Liver Neoplasms, Risk Assessment, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
